Table of Contents Executive Summary 1 Industry Overview of Recombinant Protein Drugs 1.1 Definition of Recombinant Protein Drugs 1.2 Recombinant Protein Drugs Segment by Type 1.2.1 Global Recombinant Protein Drugs Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Recombinant DNA 1.2.3 Recombinant RNA 1.3 Recombinant Protein Drugs Segment by Applications 1.3.1 Global Recombinant Protein Drugs Consumption Comparison by Applications (2014-2025) 1.3.2 Pharmaceutical Industry 1.3.3 Other 1.4 Global Recombinant Protein Drugs Overall Market 1.4.1 Global Recombinant Protein Drugs Revenue (2014-2025) 1.4.2 Global Recombinant Protein Drugs Production (2014-2025) 1.4.3 North America Recombinant Protein Drugs Status and Prospect (2014-2025) 1.4.4 Europe Recombinant Protein Drugs Status and Prospect (2014-2025) 1.4.5 China Recombinant Protein Drugs Status and Prospect (2014-2025) 1.4.6 Japan Recombinant Protein Drugs Status and Prospect (2014-2025) 1.4.7 Southeast Asia Recombinant Protein Drugs Status and Prospect (2014-2025) 1.4.8 India Recombinant Protein Drugs Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Recombinant Protein Drugs 2.3 Manufacturing Process Analysis of Recombinant Protein Drugs 2.4 Industry Chain Structure of Recombinant Protein Drugs 3 Development and Manufacturing Plants Analysis of Recombinant Protein Drugs 3.1 Capacity and Commercial Production Date 3.2 Global Recombinant Protein Drugs Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Recombinant Protein Drugs 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Recombinant Protein Drugs Production and Capacity Analysis 4.2 Recombinant Protein Drugs Revenue Analysis 4.3 Recombinant Protein Drugs Price Analysis 4.4 Market Concentration Degree 5 Recombinant Protein Drugs Regional Market Analysis 5.1 Recombinant Protein Drugs Production by Regions 5.1.1 Global Recombinant Protein Drugs Production by Regions 5.1.2 Global Recombinant Protein Drugs Revenue by Regions 5.2 Recombinant Protein Drugs Consumption by Regions 5.3 North America Recombinant Protein Drugs Market Analysis 5.3.1 North America Recombinant Protein Drugs Production 5.3.2 North America Recombinant Protein Drugs Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Recombinant Protein Drugs Import and Export 5.4 Europe Recombinant Protein Drugs Market Analysis 5.4.1 Europe Recombinant Protein Drugs Production 5.4.2 Europe Recombinant Protein Drugs Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Recombinant Protein Drugs Import and Export 5.5 China Recombinant Protein Drugs Market Analysis 5.5.1 China Recombinant Protein Drugs Production 5.5.2 China Recombinant Protein Drugs Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Recombinant Protein Drugs Import and Export 5.6 Japan Recombinant Protein Drugs Market Analysis 5.6.1 Japan Recombinant Protein Drugs Production 5.6.2 Japan Recombinant Protein Drugs Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Recombinant Protein Drugs Import and Export 5.7 Southeast Asia Recombinant Protein Drugs Market Analysis 5.7.1 Southeast Asia Recombinant Protein Drugs Production 5.7.2 Southeast Asia Recombinant Protein Drugs Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Recombinant Protein Drugs Import and Export 5.8 India Recombinant Protein Drugs Market Analysis 5.8.1 India Recombinant Protein Drugs Production 5.8.2 India Recombinant Protein Drugs Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Recombinant Protein Drugs Import and Export 6 Recombinant Protein Drugs Segment Market Analysis (by Type) 6.1 Global Recombinant Protein Drugs Production by Type 6.2 Global Recombinant Protein Drugs Revenue by Type 6.3 Recombinant Protein Drugs Price by Type 7 Recombinant Protein Drugs Segment Market Analysis (by Application) 7.1 Global Recombinant Protein Drugs Consumption by Application 7.2 Global Recombinant Protein Drugs Consumption Market Share by Application (2014-2019) 8 Recombinant Protein Drugs Major Manufacturers Analysis 8.1 Novo Nordisk 8.1.1 Novo Nordisk Recombinant Protein Drugs Production Sites and Area Served 8.1.2 Novo Nordisk Product Introduction, Application and Specification 8.1.3 Novo Nordisk Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Amgen 8.2.1 Amgen Recombinant Protein Drugs Production Sites and Area Served 8.2.2 Amgen Product Introduction, Application and Specification 8.2.3 Amgen Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 Sanofi 8.3.1 Sanofi Recombinant Protein Drugs Production Sites and Area Served 8.3.2 Sanofi Product Introduction, Application and Specification 8.3.3 Sanofi Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Eli Lilly 8.4.1 Eli Lilly Recombinant Protein Drugs Production Sites and Area Served 8.4.2 Eli Lilly Product Introduction, Application and Specification 8.4.3 Eli Lilly Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 Merck Serono 8.5.1 Merck Serono Recombinant Protein Drugs Production Sites and Area Served 8.5.2 Merck Serono Product Introduction, Application and Specification 8.5.3 Merck Serono Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 Ortho Biotech 8.6.1 Ortho Biotech Recombinant Protein Drugs Production Sites and Area Served 8.6.2 Ortho Biotech Product Introduction, Application and Specification 8.6.3 Ortho Biotech Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 8.7 Roche 8.7.1 Roche Recombinant Protein Drugs Production Sites and Area Served 8.7.2 Roche Product Introduction, Application and Specification 8.7.3 Roche Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.7.4 Main Business and Markets Served 8.8 Kyowa Hakko Kirin 8.8.1 Kyowa Hakko Kirin Recombinant Protein Drugs Production Sites and Area Served 8.8.2 Kyowa Hakko Kirin Product Introduction, Application and Specification 8.8.3 Kyowa Hakko Kirin Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.8.4 Main Business and Markets Served 8.9 Pharmingen 8.9.1 Pharmingen Recombinant Protein Drugs Production Sites and Area Served 8.9.2 Pharmingen Product Introduction, Application and Specification 8.9.3 Pharmingen Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.9.4 Main Business and Markets Served 8.10 Abcam 8.10.1 Abcam Recombinant Protein Drugs Production Sites and Area Served 8.10.2 Abcam Product Introduction, Application and Specification 8.10.3 Abcam Recombinant Protein Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.10.4 Main Business and Markets Served 8.11 GenSci 8.12 SL PHARM 8.13 Dongbao Pharm 8.14 Ankebio 8.15 NCPC 8.16 Heng Rui 9 Development Trend of Analysis of Recombinant Protein Drugs Market 9.1 Global Recombinant Protein Drugs Market Trend Analysis 9.1.1 Global Recombinant Protein Drugs Market Size (Volume and Value) Forecast 2019-2025 9.2 Recombinant Protein Drugs Regional Market Trend 9.2.1 North America Recombinant Protein Drugs Forecast 2019-2025 9.2.2 Europe Recombinant Protein Drugs Forecast 2019-2025 9.2.3 China Recombinant Protein Drugs Forecast 2019-2025 9.2.4 Japan Recombinant Protein Drugs Forecast 2019-2025 9.2.5 Southeast Asia Recombinant Protein Drugs Forecast 2019-2025 9.2.6 India Recombinant Protein Drugs Forecast 2019-2025 9.3 Recombinant Protein Drugs Market Trend (Product Type) 9.4 Recombinant Protein Drugs Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Recombinant Protein Drugs Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Recombinant Protein Drugs Table Global Recombinant Protein Drugs Production (K Doses) Growth Rate Comparison by Types (2014-2025) Figure Global Recombinant Protein Drugs Production Market Share by Types in 2018 Figure Recombinant DNA Product Picture Figure Recombinant RNA Product Picture Table Global Recombinant Protein Drugs Consumption (K Doses) Comparison by Applications (2014-2025) Figure Global Recombinant Protein Drugs Consumption Market Share by Applications in 2018 Figure Pharmaceutical Industry Figure Other Figure Global Recombinant Protein Drugs Revenue (Million USD) (2014-2025) Figure Global Recombinant Protein Drugs Production (K Doses) (2014-2025) Figure North America Recombinant Protein Drugs Market Size (Million USD) (2014-2025) Figure Europe Recombinant Protein Drugs Market Size (Million USD) (2014-2025) Figure China Recombinant Protein Drugs Market Size (Million USD) (2014-2025) Figure Japan Recombinant Protein Drugs Market Size (Million USD) (2014-2025) Figure Southeast Asia Recombinant Protein Drugs Market Size (Million USD) (2014-2025) Figure India Recombinant Protein Drugs Market Size (Million USD) (2014-2025) Table Recombinant Protein Drugs Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Recombinant Protein Drugs in 2018 Figure Manufacturing Process Analysis of Recombinant Protein Drugs Figure Industry Chain Structure of Recombinant Protein Drugs Table Capacity and Commercial Production Date of Key Manufacturers Table Global Recombinant Protein Drugs Manufacturing Plants Distribution Table Recombinant Protein Drugs Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Recombinant Protein Drugs Capacity (K Doses) of Major Manufacturers (2014-2019) Table Recombinant Protein Drugs Production (K Doses) of Major Manufacturers (2014-2019) Table Recombinant Protein Drugs Production Market Share of Major Manufacturers (2014-2019) Figure Recombinant Protein Drugs Production Share by Manufacturers in 2018 Table Recombinant Protein Drugs Revenue (Million US$) of Major Manufacturers (2014-2019) Table Recombinant Protein Drugs Revenue Market Share of Major Manufacturers (2014-2019) Figure Recombinant Protein Drugs Revenue Share by Manufacturers in 2018 Table Recombinant Protein Drugs Average Price (USD/Dose) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Recombinant Protein Drugs Production by Regions 2014-2019 (K Doses) Table Global Recombinant Protein Drugs Production Market Share by Regions 2014-2019 Figure Global Recombinant Protein Drugs Production Market Share by Regions in 2018 Table Global Recombinant Protein Drugs Revenue by Regions 2014-2019 (Million USD) Table Global Recombinant Protein Drugs Revenue Market Share by Regions 2014-2019 Figure Global Recombinant Protein Drugs Revenue Market Share by Regions in 2018 Table Global Recombinant Protein Drugs Consumption by Regions 2014-2019 (K Doses) Table Global Recombinant Protein Drugs Consumption Market Share by Regions 2014-2019 Figure North America Recombinant Protein Drugs Production Growth Rate 2014-2019 (K Doses) Figure North America Recombinant Protein Drugs Revenue Growth Rate 2014-2019 (Million USD) Table North America Recombinant Protein Drugs Production, Consumption Import and Export (K Doses) Figure Europe Recombinant Protein Drugs Production Growth Rate 2014-2019 (K Doses) Figure Europe Recombinant Protein Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Europe Recombinant Protein Drugs Production, Consumption Import and Export (K Doses) Figure China Recombinant Protein Drugs Production Growth Rate 2014-2019 (K Doses) Figure China Recombinant Protein Drugs Revenue Growth Rate 2014-2019 (Million USD) Table China Recombinant Protein Drugs Production, Consumption Import and Export (K Doses) Figure Japan Recombinant Protein Drugs Production Growth Rate 2014-2019 (K Doses) Figure Japan Recombinant Protein Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Japan Recombinant Protein Drugs Production, Consumption Import and Export (K Doses) Figure Southeast Asia Recombinant Protein Drugs Production Growth Rate 2014-2019 (K Doses) Figure Southeast Asia Recombinant Protein Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Recombinant Protein Drugs Production, Consumption Import and Export (K Doses) Figure India Recombinant Protein Drugs Production Growth Rate 2014-2019 (K Doses) Figure India Recombinant Protein Drugs Revenue Growth Rate 2014-2019 (Million USD) Table India Recombinant Protein Drugs Production, Consumption Import and Export (K Doses) Figure Global Consumption Recombinant Protein Drugs Market Share by Application (2014-2019) Figure Global Value (Consumption) Recombinant Protein Drugs Market Share by Application (2014-2019) Table Novo Nordisk Recombinant Protein Drugs Production Sites and Area Served Table Novo Nordisk Recombinant Protein Drugs Product Introduction, Application and Specification Table Novo Nordisk Recombinant Protein Drugs Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019) Table Novo Nordisk Recombinant Protein Drugs Production Growth Rate (2014-2019) Table Novo Nordisk Recombinant Protein Drugs Production Market Share (2014-2019) Figure Novo Nordisk Recombinant Protein Drugs Revenue Market Share (2014-2019) Table Novo Nordisk Recombinant Protein Drugs Main Business and Markets Served Table Amgen Recombinant Protein Drugs Production Sites and Area Served Table Amgen Recombinant Protein Drugs Product Introduction, Application and Specification Table Amgen Recombinant Protein Drugs Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019) Table Amgen Recombinant Protein Drugs Production Growth Rate (2014-2019) Table Amgen Recombinant Protein Drugs Production Market Share (2014-2019) Figure Amgen Recombinant Protein Drugs Revenue Market Share (2014-2019) Table Amgen Recombinant Protein Drugs Main Business and Markets Served Table Sanofi Recombinant Protein Drugs Production Sites and Area Served Table Sanofi Recombinant Protein Drugs Product Introduction, Application and Specification Table Sanofi Recombinant Protein Drugs Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019) Table Sanofi Recombinant Protein Drugs Production Growth Rate (2014-2019) Table Sanofi Recombinant Protein Drugs Production Market Share (2014-2019) Figure Sanofi Recombinant Protein Drugs Revenue Market Share (2014-2019) Table Sanofi Recombinant Protein Drugs Main Business and Markets Served Table Eli Lilly Recombinant Protein Drugs Production Sites and Area Served Table Eli Lilly Recombinant Protein Drugs Product Introduction, Application and Specification Table Eli Lilly Recombinant Protein Drugs Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019) Table Eli Lilly Recombinant Protein Drugs Production Growth Rate (2014-2019) Table Eli Lilly Recombinant Protein Drugs Production Market Share (2014-2019) Figure Eli Lilly Recombinant Protein Drugs Revenue Market Share (2014-2019) Table Eli Lilly Recombinant Protein Drugs Main Business and Markets Served Table Merck Serono Recombinant Protein Drugs Production Sites and Area Served Table Merck Serono Recombinant Protein Drugs Product Introduction, Application and Specification Table Merck Serono Recombinant Protein Drugs Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019) Table Merck Serono Recombinant Protein Drugs Production Growth Rate (2014-2019) Table Merck Serono Recombinant Protein Drugs Production Market Share (2014-2019) Figure Merck Serono Recombinant Protein Drugs Revenue Market Share (2014-2019) Table Merck Serono Recombinant Protein Drugs Main Business and Markets Served Table Ortho Biotech Recombinant Protein Drugs Production Sites and Area Served Table Ortho Biotech Recombinant Protein Drugs Product Introduction, Application and Specification Table Ortho Biotech Recombinant Protein Drugs Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019) Table Ortho Biotech Recombinant Protein Drugs Production Growth Rate (2014-2019) Table Ortho Biotech Recombinant Protein Drugs Production Market Share (2014-2019) Figure Ortho Biotech Recombinant Protein Drugs Revenue Market Share (2014-2019) Table Ortho Biotech Recombinant Protein Drugs Main Business and Markets Served Table Roche Recombinant Protein Drugs Production Sites and Area Served Table Roche Recombinant Protein Drugs Product Introduction, Application and Specification Table Roche Recombinant Protein Drugs Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019) Table Roche Recombinant Protein Drugs Production Growth Rate (2014-2019) Table Roche Recombinant Protein Drugs Production Market Share (2014-2019) Figure Roche Recombinant Protein Drugs Revenue Market Share (2014-2019) Table Roche Recombinant Protein Drugs Main Business and Markets Served Table Kyowa Hakko Kirin Recombinant Protein Drugs Production Sites and Area Served Table Kyowa Hakko Kirin Recombinant Protein Drugs Product Introduction, Application and Specification Table Kyowa Hakko Kirin Recombinant Protein Drugs Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019) Table Kyowa Hakko Kirin Recombinant Protein Drugs Production Growth Rate (2014-2019) Table Kyowa Hakko Kirin Recombinant Protein Drugs Production Market Share (2014-2019) Figure Kyowa Hakko Kirin Recombinant Protein Drugs Revenue Market Share (2014-2019) Table Kyowa Hakko Kirin Recombinant Protein Drugs Main Business and Markets Served Table Pharmingen Recombinant Protein Drugs Production Sites and Area Served Table Pharmingen Recombinant Protein Drugs Product Introduction, Application and Specification Table Pharmingen Recombinant Protein Drugs Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019) Table Pharmingen Recombinant Protein Drugs Production Growth Rate (2014-2019) Table Pharmingen Recombinant Protein Drugs Production Market Share (2014-2019) Figure Pharmingen Recombinant Protein Drugs Revenue Market Share (2014-2019) Table Pharmingen Recombinant Protein Drugs Main Business and Markets Served Table Abcam Recombinant Protein Drugs Production Sites and Area Served Table Abcam Recombinant Protein Drugs Product Introduction, Application and Specification Table Abcam Recombinant Protein Drugs Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019) Table Abcam Recombinant Protein Drugs Production Growth Rate (2014-2019) Table Abcam Recombinant Protein Drugs Production Market Share (2014-2019) Figure Abcam Recombinant Protein Drugs Revenue Market Share (2014-2019) Table Abcam Recombinant Protein Drugs Main Business and Markets Served Table GenSci Recombinant Protein Drugs Production Sites and Area Served Table SL PHARM Recombinant Protein Drugs Production Sites and Area Served Table Dongbao Pharm Recombinant Protein Drugs Production Sites and Area Served Table Ankebio Recombinant Protein Drugs Production Sites and Area Served Table NCPC Recombinant Protein Drugs Production Sites and Area Served Table Heng Rui Recombinant Protein Drugs Production Sites and Area Served Figure Global Recombinant Protein Drugs Production (K Doses) Growth Rate Forecast 2019-2025 Figure Global Recombinant Protein Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Recombinant Protein Drugs Sales Price (USD/Dose) Forecast 2019-2025 Figure North America Recombinant Protein Drugs Production Growth Rate Forecast 2019-2025 (K Doses) Figure North America Recombinant Protein Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Recombinant Protein Drugs Production Growth Rate Forecast 2019-2025 (K Doses) Figure Europe Recombinant Protein Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Recombinant Protein Drugs Production Growth Rate Forecast 2019-2025 (K Doses) Figure China Recombinant Protein Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Recombinant Protein Drugs Production Growth Rate Forecast 2019-2025 (K Doses) Figure Japan Recombinant Protein Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Recombinant Protein Drugs Production Growth Rate Forecast 2019-2025 (K Doses) Figure Southeast Asia Recombinant Protein Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Recombinant Protein Drugs Production Growth Rate Forecast 2019-2025 (K Doses) Figure India Recombinant Protein Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Doses) of Recombinant Protein Drugs by Type (2019-2025) Table Global Consumption (K Doses) of Recombinant Protein Drugs by Application (2019-2025) Table Recombinant Protein Drugs Distributors List Table Recombinant Protein Drugs Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Novo Nordisk Amgen Sanofi Eli Lilly Merck Serono Ortho Biotech Roche Kyowa Hakko Kirin Pharmingen Abcam GenSci SL PHARM Dongbao Pharm Ankebio NCPC Heng Rui